Upcoming Events

Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE).

Past Events

Introduction to Innovation in Medical Evidence and Development Surveillance (IMEDS): The Research Resource
On October 30, 2024, we held a one-hour session on IMEDS, a flagship program of the Regan-Udall Foundation for the FDA.
Biosimilar Roundtables
The Reagan-Udall Foundation for the FDA conducted a series of five closed-door virtual roundtable conversations with biosimilar developers to explore emerging areas of regulatory science and to create a space for active discussion and exploration between FDA and biosimilar developers.
LDT Industry Education: Record Keeping and Adverse Event Reporting
Record Keeping and Adverse Event Reporting: Medical Device Reporting, Corrections and Removals and Quality System Complaint Requirements LDT Industry Education
Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub
The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Disease Innovation Hub, hosted a public meeting on October 16, 2024.
Virtual Public Meeting on FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods
Advancing Treatments for Post-Traumatic Stress Disorder
The Reagan-Udall Foundation for the FDA, in support of FDA’s ongoing focus on PTSD, convened “Advancing Treatments for Post-Traumatic Stress Disorder,” a public meeting with stakeholder comment.
Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence
The Reagan-Udall Foundation for the FDA, in collaboration with the Bill & Melinda Gates Foundation, will host a hybrid public workshop on "Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence."
-
Online Controlled Substances Summit
The Food and Drug Administration (FDA) and the Reagan-Udall Foundation for the FDA convened the fifth Online Controlled Substances Summit.
Implementing the RAISE Action Framework
Implementing the RAISE Action Framework Webinar July 16, 2024 | 2-3pm (eastern)  
Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest
The Reagan-Udall Foundation for the FDA, in collaboration with the FDA, hosted a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."